MP15-04 PRESENCE OF HPV IN PROSTATE TISSUE FROM PATIENTS SUBMITTED TO PROSTATE BIOPSY

Abstract

You have accessJournal of UrologyCME1 Apr 2023MP15-04 PRESENCE OF HPV IN PROSTATE TISSUE FROM PATIENTS SUBMITTED TO PROSTATE BIOPSY Nalisson Pereira, Emerson Martins, Mateus Quintela, Arthur Cunha, and Jaques Waisberg Nalisson PereiraNalisson Pereira More articles by this author , Emerson MartinsEmerson Martins More articles by this author , Mateus QuintelaMateus Quintela More articles by this author , Arthur CunhaArthur Cunha More articles by this author , and Jaques WaisbergJaques Waisberg More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003235.04AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Prostate cancer (PCa) is the second most common cancer among men. Environmental and hereditary factors are assumed to play crucial roles in prostate carcinogenesis. In addition, increasing epidemiological evidence, along with molecular research, suggests that viral infection would be a potential cofactor for the development of PCa. Recently, it has been estimated that virus infection represents approximately 10% of the worldwide cancer burden. HPV, one of the most important oncogenic viruses. Based on the genomic sequence of L1, the gene encoding the main capsid protein, more than 200 types of HPV have been identified and characterized, with at least 14 high-risk types which may cause cancer. The aim of this study was to evaluate the presence of HPV in prostate tissue in patients undergoing transrectal ultrasound-guided prostate biopsy and its possible relationship with prostate cancer. METHODS: 157 prostate tissue samples were obtained from patients undergoing screening for PCa by transrectal ultrasound guided biopsy, collected at IOM (Instituto de Oncologia e Mastologia de Macapá, Amapá, Brazil) from December 2018 to January 2021. One fragment was placed in a microcentrifuge tube with 1mL of RNAlater. After collection, the vials were stored at -20C until being processed. Total DNA extraction was performed in the Microbiology and Immunology Laboratory of the Federal University of Amapá (UNIFAP). The Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR) method was used for HPV detection. The analysis to investigate the relationship between the presence of HPV and cancer was the extension of Fisher's exact test and the alpha significance level equal to 5% was applied. RESULTS: 157 patients, 95 (60.5%) with PCa, 55 (35.0%) without cancer, and 7 (4.5%) as inconclusive (ASAP). The presence of HPV was 7/95 =(7.4%) in patients with cancer, and 2/55 =(3.6%) in those without evidence of cancer or inconclusive diagnosis ASAP. The inferential results revealed that the presence of HPV was not related to the diagnosis of cancer when the ASAP diagnosis was considered in the analysis (p=0.663) and, also when the ASAP diagnosis was not included (p=0.487). CONCLUSIONS: There was no L1 gene expression and significant levels of HPV L1 in prostate tissue. These findings suggest no oncogenic activity of HPV in PCa. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e192 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Nalisson Pereira More articles by this author Emerson Martins More articles by this author Mateus Quintela More articles by this author Arthur Cunha More articles by this author Jaques Waisberg More articles by this author Expand All Advertisement PDF downloadLoading ...